Old Web
English
Sign In
Acemap
>
Paper
>
Co-clinical trial of olaparib and temozolomide in SCLC PDX models uncovers new biomarkers of sensitivity
Co-clinical trial of olaparib and temozolomide in SCLC PDX models uncovers new biomarkers of sensitivity
2018
Benjamin J. Drapkin
Julie George
Marcello Stanzione
Beow Y. Yeap
Mari Mino–Kenudson
Camilla L. Christensen
Ruben Dries
Sarah Phat
Jun Zhong
David T. Myers
Joseph A. LiCausi
Tilak Sundaresan
Marina Kem
Nima Abedpour
L. Sequist
Alice T. Shaw
Aaron N. Hata
Mehmet Toner
Shyamala Maheswaran
Daniel A. Haber
Martin Peifer
Roman K. Thomas
Anna F. Farago
Nicholas J. Dyson
Keywords:
Clinical trial
Oncology
Internal medicine
Olaparib
Biomarker (medicine)
Medicine
Temozolomide
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]